Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

22.2%

2 terminated/withdrawn out of 9 trials

Success Rate

77.8%

-8.7% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

114%

8 of 7 completed trials have results

Key Signals

8 with results

Enrollment Performance

Analytics

Phase 2

4(44.4%)

Phase 3

4(44.4%)

Phase 1

1(11.1%)

9Total

Phase 2(4)

Phase 3(4)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT03649321Phase 1Terminated

Clinical Trial of Chemotherapy and Bemcentinib for Metastatic Pancreatic Cancer

Role: collaborator

NCT01660893Phase 3Terminated

Comparison of Intranasal Kovacaine Mist, Tetracaine Alone, and Placebo for Anesthetizing Maxillary Teeth

Role: collaborator

NCT01701505Phase 2Completed

Dose-Ranging Study of Intranasal Kovacaine Mist in Pediatric Subjects

Role: collaborator

NCT01844830Phase 3Completed

Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Pediatric Patients

Role: collaborator

NCT01807624Phase 2Completed

Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)

Role: collaborator

NCT01710787Phase 3Completed

Comparison of Intranasal Kovacaine Mist, Tetracaine Alone, and Placebo for Anesthetizing Maxillary Teeth in Adults

Role: collaborator

NCT01745380Phase 3Completed

Comparison of Intranasal Kovacaine Mist, and Placebo for Anesthetizing Maxillary Teeth in Adults

Role: collaborator

NCT01479517Phase 2Completed

Open-Label Study of Efficacy and Recommended Dose of Kovacaine Mist for Anesthetizing Maxillary Teeth

Role: collaborator

NCT01952990Phase 2Completed

Safety and Pharmacokinetics of Kovacaine Nasal Spray in Pediatric Subjects

Role: collaborator

All 9 trials loaded